Lexeo Therapeutics, Inc. Common Stock (LXEO) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
LXEO has 3 Form 4 insider filings recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001907108 (2026-04-11) ↗